ES2156889T3 - Compuestos biciclicos antagonistas de receptores de aminoacidos excitativos. - Google Patents

Compuestos biciclicos antagonistas de receptores de aminoacidos excitativos.

Info

Publication number
ES2156889T3
ES2156889T3 ES94307522T ES94307522T ES2156889T3 ES 2156889 T3 ES2156889 T3 ES 2156889T3 ES 94307522 T ES94307522 T ES 94307522T ES 94307522 T ES94307522 T ES 94307522T ES 2156889 T3 ES2156889 T3 ES 2156889T3
Authority
ES
Spain
Prior art keywords
amino acids
excitative
antagonist
receivers
bicycle compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94307522T
Other languages
English (en)
Inventor
James Allen Monn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2156889T3 publication Critical patent/ES2156889T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Abstract

EN ESTA INVENCION SE PRESENTAN NUEVOS COMPUESTOS BICICLICOS DE LA FORMULA I EN LA QUE W, R1, R2, R3, N, M Y P REPRESENTAN LO INDICADO EN LA ESPECIFICACION, Y QUE SON UTILES COMO ANTAGONISTAS DEL RECEPTOR DE AMINOACIDOS EXCITANTES Y PARA EL TRATAMIENTO DE TRASTORNOS NEUROLOGICOS. EN ESTA INVENCION TAMBIEN SE PRESENTAN LOS INTERMEDIOS UTILES PARA LA SINTESIS DE LOS ANTAGONISTAS DE AMINOACIDOS EXCITANTES.
ES94307522T 1993-10-18 1994-10-13 Compuestos biciclicos antagonistas de receptores de aminoacidos excitativos. Expired - Lifetime ES2156889T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/138,664 US5491241A (en) 1993-10-18 1993-10-18 Bicyclic intermediates for excitatory amino acid receptor antagonists

Publications (1)

Publication Number Publication Date
ES2156889T3 true ES2156889T3 (es) 2001-08-01

Family

ID=22483074

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94307522T Expired - Lifetime ES2156889T3 (es) 1993-10-18 1994-10-13 Compuestos biciclicos antagonistas de receptores de aminoacidos excitativos.

Country Status (11)

Country Link
US (2) US5491241A (es)
EP (1) EP0648762B1 (es)
JP (1) JPH07149724A (es)
AT (1) ATE201406T1 (es)
CA (1) CA2117852A1 (es)
DE (1) DE69427262T2 (es)
DK (1) DK0648762T3 (es)
ES (1) ES2156889T3 (es)
GR (1) GR3036429T3 (es)
PT (1) PT648762E (es)
SI (1) SI0648762T1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) * 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
AU733880B2 (en) 1996-09-27 2001-05-31 Eisai Inc. Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
CN101007789B (zh) * 2006-01-27 2014-08-20 北京摩力克科技有限公司 取代五元氮杂环盐类化合物及其治疗蛋白老化相关疾病的用途
EP2029536B1 (en) 2006-04-28 2013-08-28 Laboratorios Del. Dr. Esteve, S.A. Bicyclic tetrahydropyrrole compounds
EP1849771A1 (en) * 2006-04-28 2007-10-31 Laboratorios Del Dr. Esteve, S.A. Bicyclic tetrahydropyrrole compounds
EP1849770A1 (en) * 2006-04-28 2007-10-31 Laboratorios Del Dr. Esteve, S.A. Production process for bicyclic tetrahydropyrrole compounds
EP1849772A1 (en) * 2006-04-28 2007-10-31 Laboratorios Del Dr. Esteve, S.A. Bicyclic tetrahydropyrrole compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3322530A1 (de) * 1983-06-23 1985-01-10 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von mono-, bi- und tricyclischen aminosaeuren
EP0331609A3 (de) * 1988-01-27 1992-07-01 Hoechst Aktiengesellschaft Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
SE9003652D0 (sv) * 1990-11-15 1990-11-15 Astra Ab New heterocyclic compounds
US5319095A (en) * 1992-12-04 1994-06-07 Eli Lilly And Company Synthesis of kainic acid

Also Published As

Publication number Publication date
PT648762E (pt) 2001-08-30
US5641798A (en) 1997-06-24
EP0648762A2 (en) 1995-04-19
DE69427262D1 (de) 2001-06-28
JPH07149724A (ja) 1995-06-13
EP0648762A3 (en) 1995-04-26
DK0648762T3 (da) 2001-07-30
SI0648762T1 (en) 2001-10-31
CA2117852A1 (en) 1995-04-19
EP0648762B1 (en) 2001-05-23
US5491241A (en) 1996-02-13
GR3036429T3 (en) 2001-11-30
DE69427262T2 (de) 2001-10-31
ATE201406T1 (de) 2001-06-15

Similar Documents

Publication Publication Date Title
MX9305294A (es) Compuestos de decahidroisoquinolina, procedimiento para su preparacion y formulacion farmaceutica que los comprende.
UY27258A1 (es) Derivados de dihidro-benzo b 1, 4 diazepin-2-ona como antagonistas ii mglur2
DK0640592T3 (da) N-acylerede tricycliske azaheteroringe anvendelige som vasopressin-antagonister
GT199900146A (es) Derivados de 4,4-biarilpiperidina.
ES2158513T3 (es) Compuestos de n-((1,2,4)triazoloazinil)bencenosulfonamida y piridinsulfonamida, y su uso como herbicidas.
HN1998000157A (es) Agonistas de prostaglandinas
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
GT199700079A (es) Derivados triciclos sustituidos con fenilamino
UY27259A1 (es) Derivados de dihidro-benzo b 1, 4- diazepin-2ona como antagonistas i de mglur2
ECSP056097A (es) Antagonistas del receptor cgrp
ES2175350T3 (es) Compuestos triciclicos que tienen afinidad de union a receptores de melatonina, su produccion y uso.
ECSP034640A (es) Derivados de feniletenilo o feniletinilo como antagonistas del receptor del glutamato
ES2060026T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas olefinicas.
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
GT200200143A (es) Uso de los antagonistas del receptor nk-1 para el tratamiento de lesiones cerebrales, espinales o neuronales
ES2158452T3 (es) Uso de agonistas y antagonistas de estrogenos en la fabricacion de un medicamento para el tratamiento de la ateroesclerosis, independientemente de la disminucion de lipidos.
TR200001733T2 (tr) İktidarsızlığın tedavisi için etkili kombinasyon.
ES2156889T3 (es) Compuestos biciclicos antagonistas de receptores de aminoacidos excitativos.
PA8457001A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol
UY27232A1 (es) Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos
ES2161377T3 (es) Derivados de octahidro-pirrolo(1,2-a)-pirazina 2,7-sustituidos.
BRPI0412843A (pt) lactamas substituìdas e uso das mesmas como agentes anticáncer
ES2152328T3 (es) Antagonistas del receptor del fibrinogeno.
ES2149504T3 (es) Imidazo(1,2-a)quinoxalin-4-aminas activas como antagonistas de la adenosina, procedimiento para su preparacion y composiciones farmaceuticas de las mismas.
UY27998A1 (es) Piperazinas sustituidas sustituidas heterocíclicas para el tratamiento de la esquizofrenia

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 648762

Country of ref document: ES